基因组不稳定性
生物
癌症研究
拉明
基因组
核板
PVT1型
癌症
转录组
DNA复制
恶性肿瘤
细胞生物学
调节器
DNA损伤
DNA修复
核糖核酸
肺癌
遗传学
核DNA
癌变
基因表达调控
细胞核
染色质
突变
染色体不稳定性
基因表达
基因组DNA
癌细胞
核孔
基因组学
疾病
微核试验
核蛋白
基因
DNA
作者
Christopher W. Schultz,Sourav Saha,Anjali Dhall,Yang Zhang,Parth Desai,Lőrinc Sándor Pongor,David A. Scheiblin,Valentin Magidson,Ravi Prakash Shukla,Robin Sebastian,Umeshkumar Vekariya,Samreen Ahmed,Yilun Sun,Christophe E. Redon,Suresh Kumar,Manan Krishnamurthy,Henrique Bregolin Dias,Vasilisa Aksenova,Elizabeth Giordano,Nobuyuki Takahashi
标识
DOI:10.1073/pnas.2503387122
摘要
Lamin A/C (LMNA), a key component of the nuclear envelope, is essential for maintaining nuclear integrity and genome organization [W. Xie et al., Curr. Biol. 26, 2651-2658 (2016)]. While LMNA dysregulation has been implicated in genomic instability across cancer and aging, the underlying mechanisms remain poorly understood [S. Graziano et al., Nucleus 9, 258-275 (2018)]. Here, we define a mechanistic role for LMNA in preserving genome stability in small-cell lung cancer (SCLC), a malignancy marked by extreme genomic instability [N. Takahashi et al., Cancer Res. Commun. 2, 503-517 (2022)]. LMNA depletion promotes R-loop accumulation, transcription-replication conflicts, replication stress, DNA breaks, and micronuclei formation. Mechanistically, LMNA deficiency disrupts nuclear pore complex organization, specifically reducing phenylalanine-glycine (FG)-nucleoporin incorporation, resulting in impaired RNA export and nuclear retention of RNA. LMNA expression is repressed by EZH2 and reexpressed during SCLC differentiation from neuroendocrine (NE) to non-NE states, and low LMNA levels correlate with poor clinical outcomes. These findings establish LMNA as a key regulator of nuclear transport and genome integrity, linking nuclear architecture to SCLC progression and therapeutic vulnerability.
科研通智能强力驱动
Strongly Powered by AbleSci AI